HBP Recombinant Rabbit mAb (SDT-506-54)

產(chǎn)品型號(hào)：S0B3174

更新時(shí)間：2025-10-07

廠商性質(zhì)：生產(chǎn)廠家

訪問(wèn)量：136

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

GFAP Mouse mAb的應(yīng)用領(lǐng)域有哪些？

如何通過(guò)優(yōu)化配對(duì)抗體提升抗原檢測(cè)試劑盒性能？

斯達(dá)特HbA1c配對(duì)抗體：為糖尿病研究與臨床診斷提供原料

PITPNM3小分子抑制劑如何逆轉(zhuǎn)癌癥轉(zhuǎn)移進(jìn)程？

產(chǎn)品介紹

Heparin-binding protein （HBP）, also known as Azurocidin and cationic antimicrobial protein 37 （CAP37）, is a member of the serine protease family that includes Cathepsin G, neutrophil elastase （NE）, and proteinase 3 （PR3）. HBP has been recognized as a player in the activation and modulation of the immune response and may act to alarm the immune system. The cationic domain at one side of the protein is essential for its antimicrobial activity. It is stored in azurophil granules as well as secretory granules and as a result partly released at early stage of extravasation. HBP is involved in chemotaxis and activation of monocytes, cytokine release and phagocytosis leading to more efficient bacterial clearance. HBP is a reasonable therapeutic target for a variety of inflammatory disease conditions, and a promising biomarker in predicting development and prognosis of severe sepsis and septic shock.

上一個(gè)：S0B3179HBP Recombinant Rabbit mAb (SDT-506-99)